Top Markets
Coin of the day
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc.

ALSE
Rank in Stocks #42806
Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and... Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and therapeutic solutions, with a primary emphasis on ailments affecting the central nervous system. Their flagship experimental compound is Altropane, a molecular imaging agent developed for identifying and diagnosing Parkinson's disease and dementia. Founded in 1972, the company was previously known as Boston Life Sciences, Inc. before officially changing its name to Alseres Pharmaceuticals, Inc. in June 2007. Its operations are headquartered in Auburndale, Massachusetts.
Share Price
$0.01
Last synced: 2024-08-19
Market Cap
$61.27
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Alseres Pharmaceuticals, Inc. (ALSE)

Category

Price of ALSE with the market cap of B
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
ALSE
$0.01
Market Capitalization of Alseres Pharmaceuticals, Inc.(ALSE)
Market Cap: $61.27
As of August 2026 Alseres Pharmaceuticals, Inc. has a market cap of $61.27. This makes Alseres Pharmaceuticals, Inc. the world's 42806th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Alseres Pharmaceuticals, Inc. from 1994 to 2026
ALSE compared with Top 5 Most Popular stocks
Price of ALSE Asset B Mkt. of B Results
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$885,610,208 $61.27
$5.426T +8,856,102,082,485.28%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$722,382,035 $61.27
$4.426T +7,223,820,353,417.22%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$678,754,864 $61.27
$4.159T +6,787,548,640,753.60%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$597,776,772 $61.27
$3.663T +5,977,767,719,828.19%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$471,990,352 $61.27
$2.892T +4,719,903,519,699.25%